a ER a ER
Pill imprint a ER a ER has been identified as Erythromycin delayed-release 250 mg (erythromycin base).
Erythromycin is used in the treatment of chlamydia infection; dental abscess; strep throat; syphilis, early; bowel preparation (and more), and belongs to the drug class macrolides. There is no proven risk in humans during pregnancy.
Erythromycin 250 mg (erythromycin base) is not subject to the Controlled Substances Act.
See also related documents.
Erythromycin delayed-release Images
- Imprint:
-
a ER
a ER - Strength:
- 250 mg (erythromycin base)
- Color:
- Red / Clear
- Size:
- 22.00 mm
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Inactive Ingredients:
- cellulosic polymers
D&C Red No. 30
D&C Yellow No. 10
magnesium stearate
povidone
FD&C Blue No. 1
FD&C Red No. 3
gelatin
titanium dioxide
- Drug Class:
- Macrolides
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Abbott Laboratories
- National Drug Code (NDC):
- 00074-6301
| NDC Code | Manufacturer / Repackager |
|---|---|
| 54569-2281 | A S Medication Solutions LLC (repackager) |
| 66336-0017 | Dispensing Solutions Inc. (repackager) |
| 16590-0088 | Stat RX USA LLC (repackager) |
| 23490-5503 | Palmetto State Pharmaceuticals Inc (repackager) |
Note: Inactive ingredients may vary.
Advertisement
More Erythromycin Delayed-Release resources
- Erythromycin
- E. E. S. Suspension (Wolters Kluwer)
- Erythromycin (Wolters Kluwer)
- Erythromycin Base and Stearate (Wolters Kluwer)
- Erythromycin Delayed-Release Particles Capsules (Wolters Kluwer)
- Erythromycin Delayed-Release Tablets (Wolters Kluwer)
- Erythromycin Ethylsuccinate (Wolters Kluwer)
- Erythromycin Ethylsuccinate Drops (Wolters Kluwer)
- Erythromycin Ethylsuccinate Suspension (Wolters Kluwer)
- Erythromycin Filmtabs (Wolters Kluwer)
- Erythromycin Lactobionate (Wolters Kluwer)
- erythromycin (Cerner Multum)
- E.E.S. 100 (Micromedex) - Includes Dosage Information
- E.E.S. 200 (Micromedex) - Includes Dosage Information
- E.E.S. 400 (Micromedex) - Includes Dosage Information
- Erythrocin Stearate (Micromedex) - Includes Dosage Information
- Novo-Rythro Estolate Suspension (Micromedex) - Includes Dosage Information
- Novo-Rythro Ethyl Succinate Suspension (Micromedex) - Includes Dosage Information
- Novo-Rythro Stearate (Micromedex) - Includes Dosage Information
- erythromycin Oral, Parenteral (Micromedex) - Includes Dosage Information
- Erythromycin (AHFS DI)
- Erythrocin Injection (FDA)
- Erythromycin Capsules (FDA)
- Erythromycin Oral Suspension (FDA)
- Erythromycin Tablets (FDA)
- Erythromycin (Wolters Kluwer)
Erythromycin Delayed-Release is associated with the treatment of:
- Bacterial Endocarditis Prevention
- Bartonellosis
- Bowel Preparation
- Bronchitis
- Bullous Pemphigoid
- Campylobacter Gastroenteritis
- Chancroid
- Chlamydia Infection
- Dental Abscess
- Legionella Pneumonia
- Lyme Disease
- Lymphogranuloma Venereum
- Mycoplasma Pneumonia
- Nongonococcal Urethritis
- Ocular Rosacea
- Otitis Media
- Pemphigoid
- Pertussis
- Pharyngitis
- Pneumonia
- Rheumatic Fever Prophylaxis
- Skin Infection
- Strep Throat
- Syphilis, Early
- Upper Respiratory Tract Infection
Search Again
